Global multi-center phase I trial of the intraperitoneal infusion of anti-EpCAM x anti-CD3 bispecific antibody catumaxomab for advanced gastric carcinoma with peritoneal metastasis.

Qi, CS; Wu, SK; Kim, IH; Cai, SR; Wang, JF; Kim, ST; Wang, JY; Bai, LY; Lin, CY; Liang, ZZ; Wei, JX; Shen, L

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16): E16102